Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence
Cecilia J. Hillard, Kenneth M. Weinlander, Kara L. Stuhr
Neuroscience (2011) Vol. 204, pp. 207-229
Open Access | Times Cited: 173

Showing 1-25 of 173 citing articles:

Endocannabinoid Signaling and Synaptic Function
Pablo E. Castillo, Thomas J. Younts, Andrés E. Chávez, et al.
Neuron (2012) Vol. 76, Iss. 1, pp. 70-81
Open Access | Times Cited: 1008
Neurobiological Interactions Between Stress and the Endocannabinoid System
Maria Morena, Sachin Patel, Jaideep S. Bains, et al.
Neuropsychopharmacology (2015) Vol. 41, Iss. 1, pp. 80-102
Open Access | Times Cited: 557
Cannabis-based medicines for chronic neuropathic pain in adults
Martin Mücke, Tudor Phillips, Lukas Radbruch, et al.
Cochrane library (2018) Vol. 2020, Iss. 7
Open Access | Times Cited: 506
Endocannabinoid signalling in reward and addiction
Loren H. Parsons, Yasmin L. Hurd
Nature reviews. Neuroscience (2015) Vol. 16, Iss. 10, pp. 579-594
Open Access | Times Cited: 420
Modulating the endocannabinoid system in human health and disease – successes and failures
Pál Pacher, George Kunos
FEBS Journal (2013) Vol. 280, Iss. 9, pp. 1918-1943
Open Access | Times Cited: 369
Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?
Cecilia J. Hillard
Neuropsychopharmacology (2017) Vol. 43, Iss. 1, pp. 155-172
Open Access | Times Cited: 360
Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axis
Matthew N. Hill, Jeffrey G. Tasker
Neuroscience (2011) Vol. 204, pp. 5-16
Open Access | Times Cited: 310
Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks
Matthew N. Hill, Linda M. Bierer, Iouri Makotkine, et al.
Psychoneuroendocrinology (2013) Vol. 38, Iss. 12, pp. 2952-2961
Open Access | Times Cited: 228
Endocannabinoid-mediated retrograde modulation of synaptic transmission
Takako Ohno‐Shosaku, Masanobu Kano
Current Opinion in Neurobiology (2014) Vol. 29, pp. 1-8
Open Access | Times Cited: 214
Synaptic functions of endocannabinoid signaling in health and disease
Alfonso Araque, Pablo E. Castillo, Olivier J. Manzoni, et al.
Neuropharmacology (2017) Vol. 124, pp. 13-24
Open Access | Times Cited: 204
Acute Stress Increases Circulating Anandamide and Other N-Acylethanolamines in Healthy Humans
Andrea Dlugos, Emma Childs, Kara L. Stuhr, et al.
Neuropsychopharmacology (2012) Vol. 37, Iss. 11, pp. 2416-2427
Open Access | Times Cited: 205
Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis)
Mary‐Ann Fitzcharles, Christoph Baerwald, Jacob N. Ablin, et al.
Der Schmerz (2016) Vol. 30, Iss. 1, pp. 47-61
Closed Access | Times Cited: 135
Stress regulates endocannabinoid-CB1 receptor signaling
Cecilia J. Hillard
Seminars in Immunology (2014) Vol. 26, Iss. 5, pp. 380-388
Open Access | Times Cited: 113
Cannabinoids for fibromyalgia
Brian Walitt, Petra Klose, Mary‐Ann Fitzcharles, et al.
Cochrane library (2016)
Open Access | Times Cited: 112
Pathological Overeating: Emerging Evidence for a Compulsivity Construct
Catherine F. Moore, Valentina Sabino, George F. Koob, et al.
Neuropsychopharmacology (2016) Vol. 42, Iss. 7, pp. 1375-1389
Open Access | Times Cited: 106
2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons
Alvaro Llorente‐Berzal, Ana Luisa B. Terzian, Vincenzo Di Marzo, et al.
Psychopharmacology (2015) Vol. 232, Iss. 15, pp. 2811-2825
Closed Access | Times Cited: 97
The Dynamic Role of Microglia and the Endocannabinoid System in Neuroinflammation
A. P. Young, Eileen M. Denovan‐Wright
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 54
Circulating endocannabinoids and genetic polymorphisms as predictors of posttraumatic stress disorder symptom severity: heterogeneity in a community-based cohort
Terri A. deRoon‐Cassini, Carisa Bergner, Samantha A. Chesney, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 45
Cannabis-based medicines and medical cannabis for adults with cancer pain
Winfried Häuser, Patrick Welsch, Lukas Radbruch, et al.
Cochrane library (2023) Vol. 2023, Iss. 6
Open Access | Times Cited: 28
Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance
George Jîtcă, Bianca Eugenia Ősz, Camil-Eugen Vari, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 485-485
Open Access | Times Cited: 23
Estimation of reference intervals of five endocannabinoids and endocannabinoid related compounds in human plasma by two dimensional-LC/MS/MS
Flaminia Fanelli, Valentina D. Di Lallo, Ilaria Belluomo, et al.
Journal of Lipid Research (2011) Vol. 53, Iss. 3, pp. 481-493
Open Access | Times Cited: 97
Ventral Tegmental Area Cannabinoid Type-1 Receptors Control Voluntary Exercise Performance
Sarah Dubreucq, Audrey Durand, Isabel Matias, et al.
Biological Psychiatry (2012) Vol. 73, Iss. 9, pp. 895-903
Closed Access | Times Cited: 92
Peripheral Endocannabinoid System Dysregulation in First-Episode Psychosis
Miquel Bioque, Borja García‐Bueno, Karina S. MacDowell, et al.
Neuropsychopharmacology (2013) Vol. 38, Iss. 13, pp. 2568-2577
Open Access | Times Cited: 85
Endocannabinoid-Mediated Plasticity in Nucleus Accumbens Controls Vulnerability to Anxiety after Social Defeat Stress
Clémentine Bosch‐Bouju, Thomas Larrieu, Louisa Linders, et al.
Cell Reports (2016) Vol. 16, Iss. 5, pp. 1237-1242
Open Access | Times Cited: 82
Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma
Judit Lazáry, Nóra Eszlári, Gabriella Juhász, et al.
European Neuropsychopharmacology (2016) Vol. 26, Iss. 6, pp. 1020-1028
Open Access | Times Cited: 75
Page 1 - Next Page

Scroll to top